T Cell Receptor Gene Usage in Desmoglein-3-Specific T Lymphocytes from Patients with Pemphigus Vulgaris

Journal of Investigative Dermatology

Volumn 121, Issue 6, 2003, Pages 1365-1372

  Hacker Foegen, Mary K ^a   Fairley, Janet A ^a,b   Lin, Mong Shang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Desmosome; Gene rearrangement

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; DESMOGLEIN 3; EPITOPE; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DESMOSOME; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

EID: 0347624707     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1747.2003.12601.x     Document Type: Article

References (45)

1. Ahmed AR, Wagner R, Khatri K, Notani G, Awdeh Z, Apler CA, Yunis EJ: Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 88:5056-5060, 1991
2. Acha-Orbea H, Mitchell DJ, Timmermann L, et al: Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allow specific intervention. Cell 54:263-273, 1988
3. Bentley GA, Boulot G, Mariuzza RA: The structure of the antigen-binding site of immunoglobulins and T-cell receptors. Res Immunol 146:277-290, 1995
4. Bourdette DN, Chou YK, Whitham RH, et al: Immunity to T cell receptor peptides in multiple sclerosis. III Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. J Immunol 161:1034-1044, 1998
5. Casrouge A, Beaudoing E, Dalle S, Pannetier C, Kanellopoulos J, Kourilsky P: Size estimate of the alpha beta TCR repertoire of naïve mouse splenocytes. J Immunol 164:5782-5787, 2000
6. Chang JC, Smith LR, Froning KJ, et al: CD8+ T cells ion psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Ann NY Acad Sci 756:370-381, 1995
7. Chothia C, Boswell DR, Lesk AM: The outline structure of the T-cell αβ receptor. EMBO J 7:3745-3755, 1988
8. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355, 1994
9. Desiderio SV, Yancopoulos GD, Paskind M, et al: Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311:752-755, 1984
10. Edouard P, Thivolet C, Bedossa P, et al: Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD mice. Eur J Immunol 23:727-733, 1993
11. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D: Mice lacking TdT: Mature animals with an immature lymphocyte repertoire. Science 261:1175-1178, 1993
12. Hamano T, Asano Y, Iwasaki T, Yamasaki T, Hase K, Kakishita E: Direct interaction between an antigen-specific B cell clones and an MHC class II-reactive helper T cell clone. J Leukoc Biol 52:89-96, 1992
13. Hemmer B, Vergelli M, Tasnquill L, Conlon P, Ling N, McFarland HF, Marin R: Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype. Neurology 49:1116-1126, 1997
14. Heufelder AE, Bahn RS, Scriba PC: Analysis of T-cell antigen receptor variable region usage in patients with thyroid-related pretibial dermopathy. J Invest Dermatol 105:372-378, 1995
15. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW: Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668-670, 1989
16. Infante AJ, Levcovitz H, Gordon V, Wall KA, Thompson PA, Krilick KA: Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. J Immunol 148:3385-3390, 1992
17. Komori T, Okada A, Stewart V, Alt FW: Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261:1171-1175, 1993
18. Koop BF, Rowen L, Wang K, et al: The human T-cell receptor TCRAC/TCRDC (Cα/Cδ) region. Organization, sequence, and evolution of 97.6 kb of DNA. Genomics 19:478-493, 1994
19. Lever WF: Pemphigus vulgaris. In: Lever WF (ed). Pemphigus and Pemphigoid. Springfield: Thomas, 1965
20. Lin MS, Fu CL, Aoki V, et al: Development and characterization of desmoglein-1 specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest 105:207-213, 2000
21. Lin MS, Swartz SJ, Lopez A. et al: Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 99:31-40, 1997
22. Malissen M, Trucy J, Jouvin-Marche E, Cazenave PA, Scollay R, Malissen B: Regulation of TCR alpha and beta gene allelic exclusion during T-cell development. Immunol Today 13:315-322, 1992
23. Matsumoto Y, Jee Y, Sugisaki M: Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J Immunol 164:2248-2254, 2000
24. Michalaki H, Roman-Roman S, Nicolas J, et al: In-situ preferential usage of Vα8 T-cell receptor gene segments in a patient with bullous pemphigoid. J Autoimmun 6:827-839, 1993
25. Moesta AK, Lin MS, Diaz LA, Sinha AA: T cell receptor β chain gene usage in endemic pemphigus foliaceus (Fogo Selvagem). J Invest Dermatol 119:377-383, 2002
26. Moss P, Bell J: T cell receptor usage in autoimmune disease. Springer Semin Immunolpathol 21:5-17, 1999
27. Novotny J, Tonegawa S, Saito H, Kranz DM, Eisen HN: Secondary, tertiary and quaternary structure of T-cell-specific immunoglobulin-like polypeptide chains. Proc Natl Acad Sci USA 83:742-746, 1986
28. Offiner H, Hashim GA, Vandenbark AA: T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430-432, 1991
29. Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A: Expression of two T cell receptor alpha chains: Dual receptor T cells. Science 262:422-424, 1993
30. Richert JR, Robinson ED, Camphausen K, et al: Diversity of T-cell receptor V alpha, V beta, and CDR3 expression by myelin basic protein-specific human T-cell clones. Neurology 45:1919-1922, 1995
31. Rock EP, Sibbald PR, Davis MM, Chien YH: CDR3 length in antigen-specific immune receptors. J Exp Med 179:323-328, 1994
32. Schatz DGV: (D)J recombination moves in vitro. Semin Immunol 9:149-159, 1997
33. Simone E, Daniel D, Schloot N, et al: T cell recepcor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci U S A 94:2518-2521, 1997
34. Singer PA, McEvilly RJ, Noonan DJ, Dixon FJ, Theofilopoulos AN: Clonal diversity and T-cell receptor beta-chain variable gene expression in enlarged lymph nodes of MRL-lpr/lpr lupus mice. Proc Natl Acad Sci USA 83:7018-7022, 1986
35. Szafer F, Price VH, Oksenberg JR, Steinman L: T-cell receptor repertoire V beta in alopecia areata. J Invest Dermatol 104:22S-24S, 1995
36. Uccelli A, Giunti D, Salvetti M, Risori G, Fenoglio D, Abbruzzese M, Mancardi G: A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. Clin Exp Immunol 111:186-192, 1998
37. Uematsu Y, Ryser S, Dembic Z, et al: In transgenic mice the introduced functional T cell receptor beta gene prevents expression of endogenous beta genes. Cell 52:831-841, 1988
38. Urban JL, Kumar V, Kono DH, et al: Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577-592, 1988
39. Vandenbark AA, Hashim G, Offiner H: Immunization wich a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541-544, 1989
40. Vekony MA, Holder JE, Lee AJ, Horrocks C, Eperon IC, Camp RD: Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: Analysis by anchored polymerase chain reaction and hypervariable region size spectratyping. J Invest Dermatol 109:5-13, 1997
41. Wilson RK, Lai E, Concannon P, Barth RK, Hood LE: Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev 101:149-172, 1988
42. Wilson DB, Steinman L, Gold DP: The V-region disease hypothesis: New evidence suggests it is probably wrong. Immunol Today 14:376-380, 1993
43. Yang Y, Charlton B, Schimada A, Dal Canto R, Fathman CG: Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4:189-194, 1996
44. Zamvil SS, Mitchell DJ, Lee NE, et al: Predominant expression of a T cell receptor V beta gene family in autoimmune encephalomyelitis. J Exp Med 167:1586-1596, 1988
45. Zang YC, Kozovska M, Aebischer I, et al: Restricted TCR V alpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol 10:991-998, 1998